These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 12771150

  • 1. A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression.
    Misumi S, Endo M, Mukai R, Tachibana K, Umeda M, Honda T, Takamune N, Shoji S.
    J Biol Chem; 2003 Aug 22; 278(34):32335-43. PubMed ID: 12771150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine.
    Misumi S, Nakajima R, Takamune N, Shoji S.
    J Virol; 2001 Dec 22; 75(23):11614-20. PubMed ID: 11689643
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun 22; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y, Takemura T, Chikata T, Kuwata T, Terasawa H, Fujimoto R, Kuse N, Akahoshi T, Murakoshi H, Tran GV, Zhang Y, Pham CH, Pham AHQ, Monde K, Sawa T, Matsushita S, Nguyen TV, Nguyen KV, Hasebe F, Yamashiro T, Takiguchi M.
    J Virol; 2020 Jun 01; 94(12):. PubMed ID: 32295903
    [Abstract] [Full Text] [Related]

  • 11. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK, Barnett SW, Stamatatos L.
    Virology; 2006 Nov 25; 355(2):138-51. PubMed ID: 16920175
    [Abstract] [Full Text] [Related]

  • 12. Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.
    Zuber B, Hinkula J, Vödrös D, Lundholm P, Nilsson C, Mörner A, Levi M, Benthin R, Wahren B.
    Virology; 2000 Dec 20; 278(2):400-11. PubMed ID: 11118363
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K, Hatse S, Vermeire K, Aquaro S, De Clercq E, Gerlach LO, Rosenkilde M, Schwartz TW, Skerlj R, Bridger G, Schols D.
    J Virol; 2004 Dec 20; 78(23):12996-3006. PubMed ID: 15542651
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis.
    Wang Y, Tao L, Mitchell E, Bergmeier L, Doyle C, Lehner T.
    Vaccine; 1999 Apr 09; 17(15-16):1826-36. PubMed ID: 10217580
    [Abstract] [Full Text] [Related]

  • 16. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH, Shek L, Gettie A, Blanchard J, Cheng-Mayer C.
    J Virol; 2005 Oct 09; 79(19):12296-303. PubMed ID: 16160156
    [Abstract] [Full Text] [Related]

  • 17. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.
    Infect Genet Evol; 2010 Apr 09; 10(3):356-64. PubMed ID: 19446658
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG, Soundaramourty C, Benferhat R, Le Grand R, Dereuddre-Bosquet N, Krust B, Estaquier J.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29976675
    [Abstract] [Full Text] [Related]

  • 19. Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.
    Tanaka R, Yoshida A, Murakami T, Baba E, Lichtenfeld J, Omori T, Kimura T, Tsurutani N, Fujii N, Wang ZX, Peiper SC, Yamamoto N, Tanaka Y.
    J Virol; 2001 Dec 15; 75(23):11534-43. PubMed ID: 11689635
    [Abstract] [Full Text] [Related]

  • 20. CXCR4-derived synthetic peptides inducing anti-HIV-1 antibodies.
    Hashimoto C, Nomura W, Narumi T, Fujino M, Nakahara T, Yamamoto N, Murakami T, Tamamura H.
    Bioorg Med Chem; 2013 Nov 15; 21(22):6878-85. PubMed ID: 24119449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.